Biologicals

Yellow Fever

Requirements for yellow fever vaccine, Annex 2

(Requirements for Biological Substances, No. 3, revised 1995) WHO Technical Report Series, No. 872, 1998

Proposed amendments to the Requirements for Yellow Fever Vaccines (Requirements for Biological Substances No. 3, Annex 2) WHO Technical Report Series No. 872

Upcoming events

WHO Informal Consultation on Regulatory considerations for evaluation of Ebola Vaccines intended for emergency use, WHO/HQ Geneva, Switzerland, 18-19 March 2015

WHO Informal Consultation on Stability Evaluation of Vaccines for use in a Controlled Temperature Chain, WHO/HQ Geneva, Switzerland, 24–26 March 2015

WHO Informal Consultation on Amendment for Similar Biotherapeutic products of monoclonal antibodies, WHO/HQ Geneva, Switzerland, 27–28 April 2015

WHO Informal Consultation on Regulatory risk assessment for biotherapeutic products, WHO/HQ Geneva, Switzerland, 29–30 April 2015

Contacts

Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971